Skip to main navigation
Skip to search
Skip to main content
Luxembourg Institute of Health Home
Search content at Luxembourg Institute of Health
Home
Profiles
Research units
Research output
Projects
Equipment
Datasets
Cell therapy using encapsulated cells producing endostatin
R. Bjerkvig
, T. A. Read
, P. Vajkoczy
, P. Aebischer
, W. Pralong
, S. Platt
, J. E. Melvik
, A. Hagen
, M. Dornish
*
*
Corresponding author for this work
Research output
:
Contribution to journal
›
Short survey
›
peer-review
34
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Cell therapy using encapsulated cells producing endostatin'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cell Therapy
100%
Encapsulated Cells
100%
Endostatin
100%
Tumor-associated
22%
Cross-linked Alginates
22%
Alginate Gel
22%
Sodium Alginate Beads
22%
Immune System
11%
Brain Cancer
11%
Cancer Patients
11%
Antiangiogenic Therapy
11%
Kidney
11%
Cell Viability
11%
Rat Brain
11%
Glioma Patients
11%
Encapsulation Technology
11%
Local Delivery
11%
Blood-brain Barrier
11%
Tumor Cell Invasion
11%
Antiangiogenic Activity
11%
Tumor Vasculature
11%
Vessel Density
11%
Tumor Cell Migration
11%
Microvessels
11%
293 Cells
11%
C6 Glioma Cells
11%
Microhemodynamics
11%
Sustained Drug Release
11%
Intravital Video Microscopy
11%
Aggressive Surgery
11%
Producer Cells
11%
Genetically Engineered
11%
Postoperative Radiation
11%
Postoperative Chemotherapy
11%
Neuroscience
Cell Therapy
100%
Endostatin
100%
Alginic Acid
44%
Chemotherapy
11%
Brain Cancer
11%
Glioma
11%
Blood Brain Barrier
11%
Cell Invasion
11%
Cell Migration
11%
Cell Viability
11%
Microvessel
11%
Pharmacology, Toxicology and Pharmaceutical Science
Endostatin
100%
Alginic Acid
44%
Neoplasm
33%
Rat
22%
Antiangiogenic
11%
Antiangiogenic Therapy
11%
Cell Viability
11%
Sustained Release
11%
Brain Cancer
11%
Glioblastoma
11%
Tumor Vascularization
11%
Chemotherapy Regimens
11%
Blood-Brain Barrier
11%
Glioma
11%